Closing Strong: Psyence Biomedical Ltd. (PBM) Ends at 0.60, Up 0.33 from Last Close

In the journey to outperform the market, investors delve into the art of stock selection. Choosing the right stocks can be a powerful driver for wealth accumulation.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

After finishing at $0.60 in the prior trading day, Psyence Biomedical Ltd. (NASDAQ: PBM) closed at $0.60, up 0.33%. In other words, the price has increased by $0.33 from its previous closing price. On the day, 6.6 million shares were traded. PBM stock price reached its highest trading level at $0.625 during the session, while it also had its lowest trading level at $0.574.

Ratios:

Our goal is to gain a better understanding of PBM by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 0.01 and its Current Ratio is at 0.01.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, PBM now has a Market Capitalization of 8034420.

Stock Price History:

Over the past 52 weeks, PBM has reached a high of $14.55, while it has fallen to a 52-week low of $0.51. The 50-Day Moving Average of the stock is -27.67%, while the 200-Day Moving Average is calculated to be -89.54%.

Shares Statistics:

The stock has traded on average 274.69K shares per day over the past 3-months and 606850 shares per day over the last 10 days, according to various share statistics. A total of 13.39M shares are outstanding, with a floating share count of 4.70M. Insiders hold about 64.90% of the company’s shares, while institutions hold 15.68% stake in the company.

Most Popular